Discover in this France 3 TV report the collaboration between the CRCT team led by Dr. Pierre Cordelier and the Toulouse start-up Neovirtech: a therapeutic innovation opening up new perspectives in the treatment of cancer.
- The rapid progression and poor prognosis of pancreatic cancer: a therapeutic lead.
- Reprogram a family of lipids to increase the efficacy of melanoma immunotherapy.
- Rapid detection of a cancer biomarker by a microfluidic chip
- The cell signalling enzymes PI3Kalpha and PI3Kβ play major roles in the body.
- A new immunotherapy strategy in melanoma patients.